T cell based diagnostic systems for the early diagnosis and immunomonitoring in the fields of transplantation;infectious and autoimmune diseases
Lophius has raised €9.7M across 5 funding rounds from 7 investors, most recently a Growth/Late round in Jul 2016. Based in Regensburg, Germany; founded 2008; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2016-07-01 | Growth/Late | €4.3M | BACH Wirtschafts-Consulting,Bayern Kapital,VRD,Wolf Biotech | View deal → |
| 2014-05-01 | Growth/Late | €2.0M | Heidelberg Innovation,S-REFIT,VRD | View deal → |
| 2011-06-01 | Growth/Late | €1.4M | Bayern Kapital,High-Tech Gr√ºnderfonds (HTGF) | View deal → |
| 2010-06-01 | Series B | €1.6M | Bayern Kapital,High-Tech Gr√ºnderfonds (HTGF) | View deal → |
| 2008-10-01 | Seed | €419k | High-Tech Gr√ºnderfonds (HTGF) | View deal → |
